The Dendritic Cell Receptor Clec9A Binds Damaged Cells via Exposed Actin Filaments
Jian-Guo Zhang, Peter E Czabotar, Antonia N Policheni, Irina Caminschi, Soo San Wan, Susie Kitsoulis, Kirsteen M Tullett, Adeline Y Robin, Rajini Brammananth, Mark F van Delft, Jinhua Lu, Lorraine A O'Reilly, Emma C Josefsson, Benjamin T Kile, Wei Jin Chin, Justine D Mintern, Maya A Olshina, Wilson Wong, Jake Baum, Mark D Wright Show all
IMMUNITY | CELL PRESS | Published : 2012
Awarded by National Health and Medical Research Council of Australia (NHMRC)
Awarded by Leukemia & Lymphoma Society
We thank A. Cowman and R. Simpson for critical discussions and L. Zhang for his assistance with CD measurements. We thank L. Connolly, H. Patsiouras, and T. Nebl for MS sequencing analysis. Crystallization trials were performed at the Bio21 Collaborative Crystallisation Centre, Australia. Diffraction data were collected at the Australian Synchrotron and we thank staff for their assistance. This work was supported by the National Health and Medical Research Council of Australia (NHMRC) program grants 454465 (KS.), 461219 (N.A.N., J.-G.Z.), and 461221 (D.C.S.H.), project grants 575546 (KS., M.H.L., IC.) and 1009145 (L.O.R.), Human Frontier Science Program (J.B.), Australian Research Council Future Fellowships (P.E.C., J.B.), NHMRC fellowships (KS., P.M.C., N.A.N., D.C.S.H.), NHMRC Career Development Fellowship (J.D.M.), Australian Cancer Research Foundation (P.M.C., D.C.S.H.), Leukemia & Lymphoma Society Grant SCOR 7413 (D.C.S.H., L.O.R.) and Fellowship (E.C.J.), Melbourne University International Research Scholarship (M.F.v.D.), and Cancer Council Victoria Postdoctoral Research Fellowship (M.F.v.D.). This work was made possible through Victorian State Government Operational Infrastructure Support and Australian Government NHMRC IRIIS.